Wael Fayad

Director/Miembro de la Junta en

Crown Laboratories, Inc.

Health Technology

Consumer Services

Finance

Perfil

Wael Fayad is the founder of Accoy Pharmaceuticals, Inc. (founded in 2015).
He is currently the Director at Crown Laboratories, Inc. (since 2020) and a Partner at Hildred Capital Management LLC (since 2018).
Previously, he served as the Chairman of Enumeral Biomedical Holdings, Inc. (2017-2018) and held a position as Vice President-Global Business Development at Forest Laboratories, Inc. Mr. Fayad holds an MBA from Concordia University (conferred in 1993) and an undergraduate degree from the American University of Beirut (conferred in 1989).

Cargos activos de Wael Fayad

Empresas	Cargo	Inicio
Hildred Capital Management LLC Hildred Capital Management LLC Investment ManagersFinance Hildred Capital invests in middle market companies located in the United States with an enterprise value of USD 50 - 500 million and revenues of USD 10 - 100 million. The firm targets companies operating in the fields of healthcare services, consumer products, information technology, medical devices and pharmaceuticals products sectors. It provides financing for growth and buyout stage capital transactions with an investment size of USD 25 - 300 million. The firm also acquires majority and minority stake positions.	Inversor de Capital Privado	01/05/2018
Crown Laboratories, Inc. Crown Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets consumer skincare, prescription dermatology and aesthetic treatment products	Director/Miembro de la Junta	01/02/2020

Todos los cargos activos de Wael Fayad

Antiguos cargos conocidos de Wael Fayad.

Empresas	Cargo	Fin
Accoy Pharmaceuticals, Inc.	Fundador	01/09/2019
ENUMERAL BIOMEDICAL HOLDINGS INC	Director Ejecutivo	29/06/2017
FOREST LABORATORIES, INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Wael Fayad.

Formación de Wael Fayad.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wael Fayad.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	7
Crown Laboratories, Inc. Crown Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets consumer skincare, prescription dermatology and aesthetic treatment products	Health Technology
Forest Laboratories, Inc. Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products	Health Technology
Enumeral Biomedical Holdings, Inc. Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells	Health Technology
Concordia University Concordia University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American University of Beirut American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hildred Capital Management LLC Hildred Capital Management LLC Investment ManagersFinance Hildred Capital invests in middle market companies located in the United States with an enterprise value of USD 50 - 500 million and revenues of USD 10 - 100 million. The firm targets companies operating in the fields of healthcare services, consumer products, information technology, medical devices and pharmaceuticals products sectors. It provides financing for growth and buyout stage capital transactions with an investment size of USD 25 - 300 million. The firm also acquires majority and minority stake positions.	Finance
Accoy Pharmaceuticals, Inc.